ClinicalTrials.gg
Drug

Verteporfin clinical trials

Also written Visudyne and BPD-MA.

studies test it
36
open now
5
in phase 3
5
first study started
1994

How each study uses Verteporfin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Verteporfin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
12 Apr 2000 · VISUDYNE · NDA 021119 (FDA, Drugs@FDA)
European Union
27 Jul 2000 · Visudyne · EMEA/H/C/000305 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Verteporfin
19
Benzoporphyrin Derivative Monoacid Ring A
4
Verteporfin Photodynamic Therapy
3
Verteporfin Injection
3

Brand

Visudyne
20

Other names

BPD-MA
4

Studies by the year they started

36 studies that test it; most in 2007 (5)

Studies that test Verteporfin, by start year
YearStudies
19941
20022
20032
20051
20064
20075
20083
20091
20111
20121
20132
20142
20162
20172
20211
20231
20242
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
18
Phase 3
5
Phase 4
6
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 27

Novartis (4) · Manhattan Eye, Ear & Throat Hospital (3) · Mayo Clinic (2) · SpectraCure AB (2) · Oklahoma State University Center for Health Sciences (1) · University College, London (1) · Sun Yat-sen University (1) · Sunnybrook Health Sciences Centre (1)

Often tested with

Tested in the same studies.

Ranibizumab (7) · Triamcinolone Acetonide (3) · Triamcinolone (3) · Photodynamic Therapy (2) · Dexamethasone (2) · Bevacizumab (2) · Aflibercept (2) · Pegaptanib (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Verteporfin.

Studies

Open first, then newest update. How each study uses Verteporfin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 36

See all 36 studies that test Verteporfin →

Given beside what is tested · 4 — Verteporfin is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Verteporfin

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Verteporfin · ClinicalTrials.gg INT006709

  • MeSH (NLM) D000077362VerteporfinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 0X9PA28K43VERTEPORFINConfirmed FDA, NLM, Wikidata
  • RxNorm 118886Confirmed FDA, Wikidata
  • Wikidata Q782318verteporfinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1014VerteporfinConfirmed FDA, Wikidata
  • DrugBank DB00460One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.